World Bank's IFC, HDFC AMC back Molbio Diagnostics IPO anchor round

Molbio Diagnostics announced the completion of its anchor round ahead of a planned initial public offering, according to reports. The Goa-based company raised Rs 281 crore from anchor investors in the pre-IPO phase. Notable participants in the anchor round included the World Bank Group's International Finance Corporation and HDFC Mutual Fund, reflecting institutional confidence in the diagnostics firm. The anchor round underscored demand from established financial institutions for exposure to the company's growth prospects.

Beyond the anchor subscription, Molbio Diagnostics completed Rs 160 crore in secondary market transactions. The announcement indicated that major brokerages covering the issue have recommended a Subscribe rating for the IPO. The full IPO, valued at Rs 940 crore, is scheduled to open on August 10, according to the provided timeline.

Molbio's IPO marks another milestone for India's diagnostics sector, which has attracted significant institutional investor interest in recent years. The participation of multilateral institutions like the IFC signals confidence in both the company's business model and the broader healthcare diagnostics opportunity in India. For market participants, the strong anchor round and brokerage recommendations suggest robust demand expectations. The diagnostics sector remains a focal point for growth-oriented investors seeking exposure to India's healthcare expansion, with IPOs in this space often reflecting broader healthcare infrastructure trends and demographic-driven demand for diagnostic services.

Source: Markets-Economic Times